Announcements Trials
Browse Landscape

Phase

Phase NA 24Phase 2 20Phase 3 8Phase 2/3 3Phase 1 2Phase 4 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 137INDUSTRY 72OTHER_GOV 3NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Thoracic 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Urogenital Neoplasms 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Prostatic Diseases 1Neoplasms by Site 1Neoplasms 1Male Urogenital Diseases 1Genital Neoplasms, Male 1Genital Diseases, Male 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × FED × Genitourinary × Clear all
NCT06706921 2024-11-27

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

VA Greater Los Angeles Healthcare System

Phase 4 Recruiting
15 enrolled
Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡